- Home
- SPCB vs ESLA Comparison
SPCB vs ESLA Comparison
Compare SPCB & ESLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPCB
- ESLA
- Stock Information
- Founded
- SPCB 1988
- ESLA 2021
- Country
- SPCB Israel
- ESLA United States
- Employees
- SPCB N/A
- ESLA N/A
- Industry
- SPCB Semiconductors
- ESLA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SPCB Technology
- ESLA Health Care
- Exchange
- SPCB Nasdaq
- ESLA Nasdaq
- Market Cap
- SPCB 50.9M
- ESLA 48.9M
- IPO Year
- SPCB N/A
- ESLA N/A
- Fundamental
- Price
- SPCB $10.72
- ESLA $2.98
- Analyst Decision
- SPCB Strong Buy
- ESLA Strong Buy
- Analyst Count
- SPCB 1
- ESLA 1
- Target Price
- SPCB $18.00
- ESLA $16.00
- AVG Volume (30 Days)
- SPCB 71.9K
- ESLA 509.9K
- Earning Date
- SPCB 11-13-2025
- ESLA 11-13-2025
- Dividend Yield
- SPCB N/A
- ESLA N/A
- EPS Growth
- SPCB N/A
- ESLA N/A
- EPS
- SPCB 0.98
- ESLA N/A
- Revenue
- SPCB $27,426,000.00
- ESLA N/A
- Revenue This Year
- SPCB N/A
- ESLA N/A
- Revenue Next Year
- SPCB $29.31
- ESLA N/A
- P/E Ratio
- SPCB $10.41
- ESLA N/A
- Revenue Growth
- SPCB 2.17
- ESLA N/A
- 52 Week Low
- SPCB $3.08
- ESLA $0.70
- 52 Week High
- SPCB $18.95
- ESLA $3.15
- Technical
- Relative Strength Index (RSI)
- SPCB 49.45
- ESLA 66.39
- Support Level
- SPCB $9.99
- ESLA $2.20
- Resistance Level
- SPCB $11.79
- ESLA $3.15
- Average True Range (ATR)
- SPCB 0.67
- ESLA 0.43
- MACD
- SPCB -0.06
- ESLA 0.03
- Stochastic Oscillator
- SPCB 46.57
- ESLA 86.13
About SPCB SuperCom Ltd. (Israel)
SuperCom Ltd is an Israel-based provider of traditional and digital identity solutions, providing safety, identification, tracking, and security products to governments and organizations. The company comprises three main Strategic Business Units: e-Gov; IoT, which is the key revenue driver; and Cyber Security. The Company's IoT products and solutions reliably identify, track and monitor people or objects in real time, enabling the customers to detect unauthorized movement of people, vehicles and other monitored objects. The geographical segments of the company include Africa, European countries, South America, the United States, Israel, and APAC.
About ESLA Estrella Immunopharma Inc.
Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors. Estrella's mission is to harness the evolutionary power of the human immune system to transform the lives of patients fighting cancer and autoimmune diseases.